AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
HKD 3.16
-$2.92 (-48.03%)
HKSE · 15 Sep 2026 08:08 UTC
Previous Close
HKD 3.17
Day Range
HKD 3.12HKD 3.27
Year Range
HKD 2.8HKD 16.8
Market Cap
1.33B
AVG Volume
1.16M
Trailing/Forward PE
-5.1/-
PEG ratio
0.1
Dividend Yield
-
Next Earnings Date
2027-03-30
Primary Exchange
Hong Kong Stock Exchange
Video analysis: 1541.HK
All videosNo video analysis for this stock yet. Request one from our team.
Similar companies
-
Antengene Corporation Limited
6996.HK
·
Hong Kong Stock Exchange
Compare
-
Jiangsu Recbio Technology Co., Ltd.
2179.HK
·
Hong Kong Stock Exchange
Compare
-
Clover Biopharmaceuticals, Ltd.
2197.HK
·
Hong Kong Stock Exchange
Compare
-
Hua Medicine (Shanghai) Ltd.
2552.HK
·
Hong Kong Stock Exchange
Compare
-
Cutia Therapeutics
2487.HK
·
Hong Kong Stock Exchange
Compare
-
Medtide Inc.
3880.HK
·
Hong Kong Stock Exchange
Compare